Related references
Note: Only part of the references are listed.PPARγ-independent antitumor effects of thiazolidinediones
Shuo Wei et al.
CANCER LETTERS (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARγ-dependent and PPARγ-independent pathways
Besstina E. Lyles et al.
CELL CYCLE (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor γ involves angiogenesis inhibition
Yu-Wei Dong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Roles of p53, Myc and HIF-1 in Regulating Glycolysis - the Seventh Hallmark of Cancer
S. J. Yeung et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Targeting AMPK: A new therapeutic opportunity in breast cancer
Sirwan M. Hadad et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells
Efstathia Papageorgiou et al.
MOLECULAR MEDICINE (2008)
Metformin induces apoptosis of pancreatic cancer cells
Luo-Wei Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling
Giulia Cantini et al.
PPAR RESEARCH (2008)
Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis
Lonneke V. van de Poll-Franse et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis
A. Isakovic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Diabetes and cancer risk for all and specific sites among Japanese men and women
Kiyonori Kuriki et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone
RE Teresi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Establishment of risk model for pancreatic cancer in Chinese Han population
Xing-Hua Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
The potential of antidiabetic thiazolidinediones for anticancer therapy
Andrea Galli et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers
RZ Stolzenberg-Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Peroxisome proliferator-activated receptor-γ figands for the treatment of breast cancer
MH Fenner et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
RG Jones et al.
MOLECULAR CELL (2005)
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
LC Richardson et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Mortality from site-specific malignancies in type 2 diabetic patients from Verona
G Verlato et al.
DIABETES CARE (2003)
Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin
CC Hudson et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Diabetes: Risk factor for the development of pancreatic cancer or manifestation of the disease?
WE Fisher
WORLD JOURNAL OF SURGERY (2001)
Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis
TIL Nilsen et al.
BRITISH JOURNAL OF CANCER (2001)
Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression
XZ Ding et al.
PANCREAS (2000)
Early stimulation of acidification rate by novel cytotoxic pyridyl cyanoguanidines in human tumor cells:: Comparison with m-iodobenzylguanidine
S Ekelund et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
